In a 65-year-old man with atherosclerotic cardiovascular disease, treated hepatitis C, hyperlipidemia, hypertension, type 2 diabetes with low hemoglobin A1c, and an electrocardiogram showing normal sinus rhythm, normal axis, low‑voltage QRS complexes and otherwise abnormal, what management is indicated for the ECG findings?

Management of Low-Voltage QRS in a Patient with ASCVD

The low-voltage QRS finding on this ECG warrants further evaluation with an echocardiogram to assess for underlying structural heart disease, particularly given this patient's ASCVD history and treated hepatitis C.

Why This ECG Finding Matters

Low-voltage QRS complexes are not a benign incidental finding—they suggest underlying pathology that requires investigation. In your patient with established atherosclerotic cardiovascular disease and treated hepatitis C, this ECG abnormality could indicate:

• Infiltrative cardiomyopathy (amyloidosis, hemochromatosis)
• Pericardial effusion
• Dilated cardiomyopathy
• Chronic ischemic heart disease with myocardial scarring
• Obesity (though less likely given the clinical context)
• COPD/emphysema (if present)

The Hepatitis C Connection

The treated hepatitis C history is particularly relevant here. HCV infection has been directly linked to cardiomyopathy through multiple mechanisms 1:

• Direct viral replication within cardiomyocytes causing myocardial injury
• Immune-mediated damage with pro-inflammatory cytokines promoting cardiomyocyte apoptosis and fibrosis
• Enhanced atherosclerotic processes through endothelial dysfunction and oxidative stress

Even after successful HCV treatment, residual cardiac effects may persist, making structural heart disease evaluation essential.

Recommended Workup Algorithm

Immediate next steps:

1. Transthoracic echocardiogram - This is the single most important test to:

   • Assess left ventricular systolic and diastolic function
   • Evaluate for wall motion abnormalities suggesting ischemic cardiomyopathy
   • Rule out pericardial effusion
   • Look for infiltrative patterns (increased wall thickness with reduced voltage suggests infiltration)
   • Measure ejection fraction

2. Review current medications - The guidelines emphasize that many cardiovascular and non-cardiovascular drugs can produce ECG changes 2. Verify if the patient is on:

   • Beta-blockers, calcium channel blockers, or ACE inhibitors (common in ASCVD patients)
   • Any antiarrhythmic agents
   • Drugs that might affect QRS voltage

3. Assess for new or changing symptoms 2:

   • Dyspnea (new or worsening)
   • Fatigue or weakness
   • Chest pain pattern changes
   • Syncope or near-syncope
   • Palpitations

Follow-Up ECG Strategy

Given this patient's known cardiovascular disease, serial ECGs are indicated per ACC/AHA guidelines 2. The guidelines specifically state that patients with known cardiovascular disease require:

• Repeat ECGs when new symptoms or findings appear
• Periodic ECGs to assess disease progression (frequency determined by clinical stability)
• Serial ECGs until the disease process stabilizes

For this patient, I recommend:

• Repeat ECG in 3-6 months if echocardiogram is normal and patient remains asymptomatic
• Earlier repeat ECG if any symptoms develop or if echocardiogram shows abnormalities requiring monitoring

Critical Pitfalls to Avoid

1. Don't dismiss low-voltage QRS as "just technical" - While improper lead placement or body habitus can cause low voltage, in a patient with ASCVD and hepatitis C history, assume pathology until proven otherwise

2. Don't rely on the A1c of 4.7% as reassurance - While excellent glycemic control is present, this doesn't exclude cardiac complications. In fact, the U-shaped relationship between HbA1c and cardiovascular outcomes means very low A1c (<5.5%) can paradoxically increase cardiovascular mortality risk 3. Consider whether diabetes management needs adjustment.

3. Don't forget the ASCVD requires aggressive risk factor management - This ECG finding is occurring in the context of established atherosclerotic disease. Ensure optimal secondary prevention 4, 5:

   • LDL-C target <70 mg/dL (ideally <55 mg/dL for very high-risk ASCVD)
   • Blood pressure <130/80 mmHg
   • Consider combination lipid-lowering therapy if not at goal

Bottom Line

Order an echocardiogram now. The combination of low-voltage QRS, established ASCVD, and treated hepatitis C creates a clinical scenario where structural heart disease is likely present and requires identification. The ECG has provided a warning signal that should not be ignored 2.